Noninvasive prenatal detection of Down syndrome: are we finally getting the right message?

References

• Bianchi DW. Fetal cells in the maternal circulation: feasibility for prenatal diagnosis. Br. J. Haematol.105, 574–583 (1999).
   PubMed Web of Science ®Google Scholar
• Hahn S, Holzgreve W. Prenatal diagnosis using fetal cells and cell-free fetal DNA in maternal blood: what is currently feasible? Clin. Obstet. Gynecol.45, 649–656 (2002).
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Simpson JL, Jackson LG et al. Fetal gender and aneuploidy detection using fetal cells in maternal blood: analysis of NIFTY I data. National Institute of Child Health and Development Fetal Cell Isolation Study. Prenat. Diagn.22, 609–615 (2002).
   PubMed Web of Science ®Google Scholar
• Lo YM, Corbetta N, Chamberlain PF et al. Presence of fetal DNA in maternal plasma and serum. Lancet350, 485–487 (1997).
   PubMed Web of Science ®Google Scholar
• Lo YM, Tein MS, Lau TK et al. Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am. J. Hum. Genet.62, 768–775 (1998).
   PubMed Web of Science ®Google Scholar
• Chiu RW, Lo YM. Noninvasive prenatal diagnosis by analysis of fetal DNA in maternal plasma. Methods Mol. Biol.336, 101–109 (2006).
   PubMedGoogle Scholar
• Finning K, Martin P, Daniels G. A clinical service in the UK to predict fetal Rh (Rhesus) D blood group using free fetal DNA in maternal plasma. Ann. NY Acad. Sci.1022, 119–123 (2004).
   PubMed Web of Science ®Google Scholar
• Bianchi DW, Avent ND, Costa JM, van der Schoot CE. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet. Gynecol.106, 841–844 (2005).
   PubMedGoogle Scholar
• Li Y, Zimmermann B, Rusterholz C, Kang A, Holzgreve W, Hahn S. Size separation of circulatory DNA in maternal plasma permits ready detection of fetal DNA polymorphisms. Clin. Chem.50, 1002–1011 (2004).
   PubMed Web of Science ®Google Scholar
• Li Y, Di NE, Vitucci A, Zimmermann B, Holzgreve W, Hahn S. Detection of paternally inherited fetal point mutations for β-thalassemia using size-fractionated cell-free DNA in maternal plasma. JAMA293, 843–849 (2005).
   PubMed Web of Science ®Google Scholar
• Chim SS, Tong YK, Chiu RW et al. Detection of the placental epigenetic signature of the maspin gene in maternal plasma. Proc. Natl Acad. Sci. USA102, 14753–14758 (2005).
   PubMed Web of Science ®Google Scholar
• Chan KC, Ding C, Gerovassili A et al. Hypermethylated RASSF1A in maternal plasma: a universal fetal DNA marker that improves the reliability of noninvasive prenatal diagnosis. Clin. Chem.52, 2211–2218 (2006).
   PubMed Web of Science ®Google Scholar
• Lo YM, Tsui NB, Chiu RW et al. Plasma placental RNA allelic ratio permits noninvasive prenatal chromosomal aneuploidy detection. Nat. Med.13, 218–223 (2007).
   PubMed Web of Science ®Google Scholar
• Lo YM, Chiu RW. The biology and diagnostic applications of plasma RNA. Ann. NY Acad. Sci.1022, 135–139 (2004).
   PubMed Web of Science ®Google Scholar
• Ng EK, Tsui NB, Lau TK et al. mRNA of placental origin is readily detectable in maternal plasma. Proc. Natl Acad. Sci. USA100, 4748–4753 (2003).
   PubMed Web of Science ®Google Scholar
• Ding C, Chiu RW, Lau TK et al. MS analysis of single-nucleotide differences in circulating nucleic acids: application to noninvasive prenatal diagnosis. Proc. Natl Acad. Sci. USA101, 10762–10767 (2004).
   PubMed Web of Science ®Google Scholar
• Dhallan R, Guo X, Emche S et al. A non-invasive test for prenatal diagnosis based on fetal DNA present in maternal blood: a preliminary study. Lancet369, 474–481 (2007).
   PubMed Web of Science ®Google Scholar
• Malone FD, Canick JA, Ball RH et al. First-trimester or second-trimester screening, or both, for Down’s syndrome. N. Engl. J. Med.353, 2001–2011 (2005).
   PubMed Web of Science ®Google Scholar
• Dhallan R, Au WC, Mattagajasingh S et al. Methods to increase the percentage of free fetal DNA recovered from the maternal circulation. JAMA291, 1114–1119 (2004).
   PubMed Web of Science ®Google Scholar
• Chinnapapagari SK, Holzgreve W, Lapaire O, Zimmermann B, Hahn S. Treatment of maternal blood samples with formaldehyde does not alter the proportion of circulatory fetal nucleic acids (DNA and mRNA) in maternal plasma. Clin. Chem.51, 652–655 (2005).
   PubMed Web of Science ®Google Scholar
• Chung GT, Chiu RW, Chan KC, Lau TK, Leung TN, Lo YM. Lack of dramatic enrichment of fetal DNA in maternal plasma by formaldehyde treatment. Clin. Chem.51, 655–658 (2005).
   PubMed Web of Science ®Google Scholar
• Tsui NB, Chim SS, Chiu RW et al. Systematic micro-array based identification of placental mRNA in maternal plasma: towards non-invasive prenatal gene expression profiling. J. Med. Genet.41, 461–467 (2004).
   PubMed Web of Science ®Google Scholar